MLICM
ARDX icon

Metropolitan Life Insurance Company (MetLife)’s Ardelyx ARDX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ARDX Stock Details ARDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,793
Closed -$86.1K – 166
2024
Q1 		$86.1K Sell
11,793
-1,391
-11% -$11.9K ﹤0.01% 1132
2023
Q4 		$81.7K Buy
13,184
+766
+6% +$3.44K ﹤0.01% 1191
2023
Q3 		$50.7K Buy
12,418
+762
+7% +$2.97K ﹤0.01% 1395
2023
Q2 		$39.5K Buy
+11,656
New +$47.8K ﹤0.01% 1570
2021
Q3 		– Sell
-26,152
Closed -$198K – 2842
2021
Q2 		$198K Buy
26,152
+14,097
+117% +$104K ﹤0.01% 2148
2021
Q1 		$79.8K Sell
12,055
-8,609
-42% -$59.1K ﹤0.01% 2476
2020
Q4 		$134K Sell
20,664
-445
-2% -$2.64K ﹤0.01% 2200
2020
Q3 		$111K Sell
21,109
-216
-1% -$1.3K ﹤0.01% 2157
2020
Q2 		$148K Buy
21,325
+630
+3% +$4.38K ﹤0.01% 2018
2020
Q1 		$118K Buy
20,695
+9,796
+90% +$66.6K ﹤0.01% 1928
2019
Q4 		$81.8K Sell
10,899
-7,389
-40% -$44.9K ﹤0.01% 2432
2019
Q3 		$86K Buy
+18,288
New +$63.5K ﹤0.01% 2377
2017
Q2 		– Sell
-22,824
Closed -$289K – 2568
2017
Q1 		$289K Hold
22,824
– – ﹤0.01% 2030
2016
Q4 		$324K Buy
22,824
+2,382
+12% +$33.8K ﹤0.01% 2042
2016
Q3 		$265K Buy
20,442
+1,311
+7% +$13.7K ﹤0.01% 2151
2016
Q2 		$167K Sell
19,131
-398
-2% -$3.25K ﹤0.01% 2444
2016
Q1 		$152K Buy
19,529
+7,103
+57% +$69.9K ﹤0.01% 2334
2015
Q4 		$225K Hold
12,426
– – ﹤0.01% 2172
2015
Q3 		$215K Buy
+12,426
New +$232K ﹤0.01% 2237

Other funds holding ARDX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ARDX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ardelyx (ARDX) in Q2 2024, closing a stake of 11,793 shares — an estimated $86.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ARDX in Q3 2015 and held it in 19 quarters. The position peaked at $324K in Q4 2016. 197 funds tracked by Wall St. Rank hold ARDX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Ardelyx position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 11,793 Ardelyx shares in Q2 2024, an estimated $86.1K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Ardelyx in Q3 2015 and held it in 19 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Ardelyx position peaked at $324K in Q4 2016.
  • 197 funds tracked by Wall St. Rank held Ardelyx as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.